This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Bravelle (Urofollitropin) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (1)
Reports by Reaction Type
Maternal Exposure During Pregnancy (1),
Abortion Spontaneous (1)
Possible Bravelle side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-19
Patient: female, weighing 79.4 kg (174.6 pounds)
Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous
Drug(s) suspected as cause:
Bravelle
Dosage: (150 -0225 iu everyday (qd))
Indication: in Vitro Fertilisation
Start date: 2009-11-01
End date: 2009-11-23
Menotropins
Indication: in Vitro Fertilisation
Start date: 2009-11-01
End date: 2009-11-23
Other drugs received by patient: Prenatal Vitamins / 01549301 /; Progesterone
|
